Levetiracetam Accord

Levetiracetam, the active ingredient in Levetiracetam Accord, is an Anticonvulsant presented as an oral dosage form for oral use. It is employed to control partial, generalized tonic‑clonic and myoclonic seizures in patients diagnosed with epilepsy.

GNH USA supplies Levetiracetam Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and reliable delivery across global markets. Our manufacturing processes adhere to EU Good Manufacturing Practice (GMP) standards, ensuring product consistency and patient safety.

Levetiracetam is an antiepileptic drug that reduces seizure activity across several seizure types.

Partial seizures: reduces frequency and severity of focal onset seizures. Generalized tonic‑clonic seizures: helps achieve seizure control in patients with primary generalized seizures. Myoclonic seizures: diminishes rapid, brief muscle jerks associated with myoclonic epilepsy.

Levetiracetam may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Dizziness: sensation of light‑headedness or imbalance. - Fatigue: unusual tiredness or lack of energy. - Headache: mild to moderate cranial pain. - Irritability: increased agitation or mood swings.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with breathing difficulty, swelling, or rash. - Mood disorders: emergence of depression, anxiety, or suicidal ideation. - Stevens‑Johnson syndrome: rare, potentially life‑threatening skin eruption.

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use. - Renal function: assess and adjust dose in patients with impaired renal clearance. - Psychiatric history: monitor for new or worsening depression or suicidal thoughts. - Concomitant CNS depressants: use caution as additive sedation may occur. - Pregnancy: evaluate risk‑benefit ratio; limited data available. - Elderly patients: start with lower dose and titrate slowly. - Store at ambient temperature: keep below 25 °C in original container, protect from moisture.

Levetiracetam can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma concentrations. - Phenobarbital: may decrease levetiracetam levels. - Phenytoin: potential reduction in levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Opioids (e.g., tramadol): increased risk of central nervous system depression. - Alcohol: may enhance dizziness and sedation. - Other antiepileptics (e.g., valproate): monitor for additive side effects.